Heghine Khachatryan: When to Consider Ehlers–Danlos Syndromes in Patients with Bleeding Symptoms?
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared European Association for Haemophilia and Allied Disorders (EAHAD)’s post on LinkedIn, adding:
”When Should We Consider Ehlers–Danlos Syndromes in Patients with Bleeding Symptoms?
Connective tissue disorders, particularly Ehlers–Danlos Syndromes (EDS), remain under-recognized in daily hematology practice — yet they frequently present with hemorrhagic manifestations that may mimic primary hemostatic disorders.
The newly released EAHAD e-learning module (Module 21) provides valuable clinical insight into:
- Recognizing red flags in patients with unexplained bleeding
- Understanding the overlap between connective tissue fragility and hemostatic abnormalities
- Improving multidisciplinary diagnostic pathways
- Avoiding misdiagnosis of inherited bleeding disorders
As clinicians working in benign hematology and hemostasis, it is essential that we broaden our differential diagnosis when laboratory results do not fully explain the clinical phenotype.
Timely identification of EDS can significantly impact patient management, perioperative planning, and long-term follow-up.
I strongly encourage colleagues involved in bleeding disorders, women’s health, and rare disease diagnostics to explore this educational resource.”
Quoting European Association for Haemophilia and Allied Disorders (EAHAD)’s post:
”Don’t miss our e-learning module on the Ehlers-Danlos Syndromes (EDS), rare, inherited multisystemic connective tissue disorders frequently associated with bleeding symptoms and haematological challenges.”
Proceed to the video attached to the post.
Find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
Mar 31, 2026, 16:05Happy National Doctors’ Day to All Physicians Making a Difference – ASH
-
Mar 31, 2026, 16:03Robert Negrin: Strengthening Collaboration with NCI to Advance Hematology Research
-
Mar 31, 2026, 16:02Jim Hoffman: Does Multiomics Suggest LC PASC Patients Require Multiple Drugs to Correct Biochemical Dysregulation?
-
Mar 31, 2026, 15:59Seema Dawood: Blister Cell in G6PD Deficiency
-
Mar 31, 2026, 15:57Ney Carter Borges: Clopidogrel vs Aspirin in Long-Term Monotherapy
-
Mar 31, 2026, 15:57Join the Webinar on Immunoglobulin Access and Stewardship in the UK and Australia – ISBT
-
Mar 31, 2026, 15:55Hind El Azzazi: Successful Defense of My Medical Doctorate on Antiphospholipid Syndrome in Men
-
Mar 31, 2026, 15:54Rucha Patil: Honored to Speak at AIIMS Nagpur ToT Workshop on Non-Factor Therapy in Hemophilia A
-
Mar 31, 2026, 15:43Deepak Sudheendra: When the Clot Is Gone, but Symptoms Remain